Nifedipine and platelets in preeclampsia.

Area of Science:

• Obstetrics and Gynecology
• Cardiology
• Hematology

Background:

• Preeclampsia is characterized by hypertension and increased platelet aggregation.
• Nifedipine is known for its antihypertensive effects and in vitro platelet inhibition.

Purpose of the Study:

• To investigate the efficacy of nifedipine in managing preeclampsia.
• To assess nifedipine's impact on blood pressure and platelet counts in preeclamptic patients.

Main Methods:

• Ten pregnant women with preeclampsia were treated with nifedipine.
• Blood pressure, platelet counts, and pregnancy duration were monitored before and during treatment.

Main Results:

• Nifedipine controlled blood pressure in 80% of patients (P < 0.02).
• Platelet counts significantly increased in all patients (P < 0.001).
• Pregnancies were prolonged by an average of 17 days.

Conclusions:

• Nifedipine effectively manages hypertension in preeclampsia.
• Nifedipine appears to reverse thrombocytopenia associated with preeclampsia.
• Nifedipine offers a potential therapeutic option for preeclampsia management.